UNSPSC 51453017: Piperazine sebacate

This classification denotes an antihelminthic agent C10H18O4.C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1EUC610UJ, chemically known as decanedioic acid, compd. with piperazine (1:1), but more generally known as piperazine sebacate, which bears US NIH Compound Identifier 3084013. European Medicines Agency schedules Piperazine sebacate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03849MIG.

Most nations, for tariff and trade purposes, schedule piperazine sebacate under HS 29335990 and SITC 51576. As of Q4 2014, PIPERAZINE SEBACATE remains US FDA's Preferred Term for this commodity. SMILES: C1CNCCN1.C(CCCCC(=O)O)CCCC(=O)O.

UNSPSC 51453017 Piperazine sebacate, a Commodity code, nominally identifies a specific chemical compound used in pharmaceutical formulations. However, the recent state and local opportunities tagged under this code show little alignment with the code's abstract scope. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium awarded to Chartwell Rx LLC procured Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—antibiotics unrelated to piperazine sebacate. Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems solicited naloxone (an opioid antagonist) and harm-reduction equipment, also unrelated to the code's nominal chemistry. State and local procurement offices appear to use this Commodity code inconsistently or as a general catch-all for pharmaceutical and medical-supply purchases rather than for the specific active pharmaceutical ingredient the code name describes.

Activity under this code spans state health departments and county government health and public-safety procurement. The two recent opportunities appear in Illinois and Florida, with no geographic concentration evident from the sparse sample. The Illinois contract, a completed piggyback award for $2,999,999.11 over three years, reflects ongoing demand for commodity pharmaceuticals through cooperative purchasing vehicles; Seminole County's procurement, an IFB with annual quantities (1,900 units of naloxone and 800 drug deactivation systems) and quarterly delivery cycles, signals repeat purchasing aligned with community health and opioid-response initiatives. Neither opportunity shows set-aside designations or domestic-product preferences. The code's mismatch with actual solicitation content suggests that vendors pursuing pharmaceutical supply contracts with state and local agencies should monitor broader pharmaceutical and medical-supply classifications rather than rely on the nominal scope of this Commodity code alone.